Literature DB >> 976920

[Serum uric acid and uric acid elimination after benzbromarone therapy in patients with gout and hyperuricemia].

F Matzkies, R Neuwirth, G Berg.   

Abstract

During treatment with benzbromaron in a dose of 100 mg/day a significant fall of uric acid was shown beginning on the second day. On the forth day in the evening or the fifth day in the morning a steady state for the uric acid level is reached. The morning value was 2,9 mg/100 ml, the evening value 2,6 mg/100 ml. During treatment, even when serum uric acid levels are decreased, an augmented renal uric acid elimination excists but a hyperuraturia was not found.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 976920

Source DB:  PubMed          Journal:  Fortschr Med        ISSN: 0015-8178


  1 in total

Review 1.  Benzbromarone: a review of its pharmacological properties and therapeutic use in gout and hyperuricaemia.

Authors:  R C Heel; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1977-11       Impact factor: 9.546

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.